Equashield to Host Symposium Featuring World's First Drug Compounding Robot with Closed System Transfer Device

PR72896

PORT WASHINGTON, New York, Apr. 3, 2018 /PRNewswire=KYODO JBN /--

       Satellite Symposium at ISOPP 2018 Focusing on Robotics in Cytotoxics to

Feature Leading Experts an Augmented Reality Tour of Equashield Pro Hazardous

Drug Compounding Robot

    Equashield [http://www.equashield.com ] (equashield.com), a

leading provider of Closed System Transfer Devices (CSTDs) for hazardous drugs,

announced today that it will be leading a symposium exploring the use of

robotics in cytotoxic drug handling at the International Symposium on Oncology

Pharmacy Practice (ISOPP).

    The symposium will introduce the Equashield Pro, the first drug compounding

robot utilizing Equashield's proprietary CSTD technology. It will also discuss

the role that the Equashield Pro will play in increasing pharmacy throughput

while simultaneously keeping pharmacists safe.

    The symposium will feature presentations from leading industry experts:

    - Yaakov Cass, District Pharmacist Emeritus for the Israeli Ministry of

Health, on Robotics in Cytotoxics: The Final Frontier.

    - Dr. Salim Hadad, Director of the Pharmaceutical Services Department at

Rambam Medical Center, on What Role Can Equashield Robots Play in Keeping

Pharmacists Safe.

    Equashield's symposium will also include an augmented reality demonstration

of the Equashield Pro robot.

    "The Equashield Pro provides the solution to hazardous drug compounding

problems encountered by practicing hospital pharmacists on a daily basis," said

Marino Kriheli, Co-Founder of Equashield. "By combining leading robotic

automation with Equashield's proprietary CSTD technology, the Equashield Pro

significantly speeds up the process of compounding hazardous drugs and creates

a safer environment for oncology pharmacists around the world."

    Utilizing advanced robotic technologies, the Equashield Pro enables quick

compounding of a large variety of patient specific chemotherapy doses using a

method that shortens the process flow while performing multiple simultaneous

tasks. Comparable in size to a standard Biological Safety Cabinet, it is easily

integrated into hospital pharmacies, while dose verification software protects

against cases of medication dosage and identification errors.

    ISOPP 2018 will be held in Shanghai, China, at the Kerry Hotel Pudong -

April 11 - 13, 2018. The Equashield symposium will take place from 12:30 -

14:00 on Wednesday, April 11. To set up a meeting with an Equashield

representative, please contact info@equashield.com or visit

https://www.equashield.com.

    About Equashield

    Equashield is a leading provider of a full range of manual and automated

solutions to hospitals for the compounding and administration of hazardous

drugs.  Equashield's product suite includes EQUASHIELD II, its flagship Closed

System Transfer Device (CSTD), and EQUASHIELD(R) Pro, the first ever closed

system drug compounding robot.  Equashield's CSTD is clinically-proven to

protect healthcare professionals from hazardous drug exposure. The globally

awarded EQUASHIELD(R) II covers more routes of exposure than alternative

systems by preventing contamination of syringe plungers and drug residuals on

connector surfaces, as well as exposure to drug vapors. Studies have shown

Equashield's CSTD to be faster to deploy and easier to use than competing

systems, and the system has passed the proposed 2015 alcohol vapor containment

protocol from NIOSH, confirming that it can contain the harshest vapors &

emissions. EQUASHIELD is in use by hundreds of hospitals and

clinics around the world, and has been both cleared by the FDA under the ONB

product code, and substantiated in FDA-cleared labeling as preventing microbial

ingress for up to seven days.

    For more information: http://www.equashield.com

    Follow Equashield on LinkedIn [https://www.linkedin.com/company/equashield

], Twitter

[https://twitter.com/Equashield ] and Facebook

[https://www.facebook.com/equashield/?fref=ts ].

    Media Contact:

    Finn Partners for Equashield

    Nicole Grubner

    nicole.grubner@finnpartners.com

    @nicolegrubner [https://twitter.com/nicolegrubner ]

    +1-929-222-8011

SOURCE: Equashield